Novartis Nearing Deal to Acquire Avidity Biosciences for Over $70 a Share: Bloomberg

Novartis AG is close to acquiring U.S.-based biotech firm Avidity Biosciences for more than $70 per share, Bloomberg News reported, citing a person familiar with the...